NephroGenex's Series B Round

NephroGenex raised a round of funding on July 12, 2010.

NephroGenex is a pharmaceutical company focused on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. Since inception, the company has collaborated wit…

Articles about NephroGenex's Series B Round: